Navigation Links
Bioheart, Inc. Announces Results of Annual Meeting
Date:7/30/2008

e information on Bioheart, visit http://www.bioheartinc.com.

MyoCell, MyoCell SDF-1 and MyoCath are trademarks of Bioheart, Inc.

Forward-Looking Statements:

Except for historical matters contained herein, statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limiting the generality of the foregoing, words such as "may", "will", "to", "plan", "expect", "believe", "anticipate", "intend", "could", "would", "estimate", or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.

Investors and others are cautioned that a variety of factors, including certain risks, may affect our business and cause actual results to differ materially from those set forth in the forward-looking statements. These risk factors include, without limitation, (i) our ability to secure additional financing; (ii) the timely success and completion of our clinical trials; (iii) the occurrence of any unacceptable side effects during or after preclinical and clinical testing of our product candidates; (iv) regulatory approval of our product candidates; (v) our dependence on the success of our lead product candidate; (vi) our inability to predict the extent of our future losses or if or when we will become profitable; (vii) our ability to protect our intellectual property rights; and (viii) intense competition. The Company is also subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" in its Annual Report on Form 10-K for the year ended December 31, 2007, as amended by Amendment No. 1 on Form 10-K/A and its quarterly report on Form 10-Q for the quarter ended March 31, 2008.

Contact: William Kline
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Bioheart, Inc. to Report Full Year 2007 Financial Results on Thursday, March 27, 2008
2. Bioheart, Inc. Announces Financial Results for First Quarter 2008
3. Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
4. Bioheart, Inc. to Host Annual Meeting of Shareholders on Wednesday, July 30, 2008
5. Bioheart, Inc. to Transfer to Nasdaq Capital Market
6. Bioheart, Inc., Added to Russell Microcap Index
7. Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
8. Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
9. Bioheart, Inc., Announces Management Change
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Asymmetrex, LLC founder ... evaluating the full range of capabilities of its unique cache of technologies for ... the day-to-day renewal and repair of normal tissues and organs. This property makes ...
(Date:7/28/2015)... ... ... The new Xsample 530 sample changer for vials can be used with Anton ... from less than 12,000 mPas (internal air) up to 36,000 (external air) – and can ... eye about Xsample 530 is its removable magazine, which is easily lifted off its hub ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... EUR 1.022 billion in 2013; while production volume reached close to 1.84 million ... country with a share of 75.5% of the region’s total aluminium hydroxide production; ...
(Date:7/28/2015)... July 28, 2015 Deerfield Management Company, L.P. ... Fund, L.P., which will invest in groundbreaking advancements in ... diseases, cancer, and orphan diseases. The venture capital fund ... therapeutics are developed and improve the way healthcare is ... the largest healthcare-focused venture funds in the sector, will ...
Breaking Biology Technology:Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4New Moves in Automatic Sample Handling: Introducing Xsample 530 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3
... TriLink BioTechnologies, Inc. (TriLink) and Lucigen Corporation (Lucigen) ... licensing agreement for the use of TriLink,s CleanAmp™ dNTPs ... TriLink,s CleanAmp™ dNTPs are an innovative approach to ... in a PCR assay with CleanAmp™ dNTPs, a Hot ...
...   Shire plc (LSE: SHP, NASDAQ: ... for the three months to June 30, 2011. ... $1,063 million +25% Non GAAP operating income $342 million +26% US ... ADS $1.33 +29% US GAAP diluted earnings per ADS $1.08 +26% ...
... Cadence Pharmaceuticals, Inc. (NASDAQ: CADX ), a biopharmaceutical ... for use in the hospital setting, today announced that it ... results on Wednesday, August 3, 2011. Cadence ... discuss the financial results on Wednesday, August 3, 2011 at ...
Cached Biology Technology:TriLink BioTechnologies, Inc. Announces License Agreement with Lucigen Corporation 2Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 2Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 3Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 4Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 5Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 6Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 7Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 8Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 9Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 10Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 11Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 12Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 13Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 14Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 15Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 16Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 17Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 18Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 19Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 20Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 21Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 22Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 23Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 24Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 25Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 26Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 27Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 28Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 29Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 30Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time 31
(Date:6/24/2015)... , June 22, 2015 ... announced the addition of the "Huawei Ascend ... report to their offering. Huawei,s ... to the opposite direction than Apple,s and Samsung,s ... fingerprint sensor developed by Fingerprint Cards, a main ...
(Date:6/23/2015)... Minn. , June 23, 2015   ... company that supports the entire spectrum of clinical ... iMedNet ™ , the company,s intuitive, ... been awarded a Silver 2015 Stevie® Award by ... Health Products & Services Website category.  The American ...
(Date:6/23/2015)... June 23, 2015   Valencell, a ... results of a recent study that illustrates its ... wrist during activity. In a study conducted at ... along with the Apple Watch against a chest ... rate during activity. The study demonstrated that Valencell,s ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... Tyco International Ltd. (NYSE: TYC ) today announced that it ... business. Tyco expects to file documents with the U.S. Securities & Exchange ... transaction in the first half of fiscal 2011. Following the transaction, the ... , , ...
... April 27, 2010 Dominio Amigo S.A.S , a .CO,accredited ... name launch. , , , ... Julio Camacho , CEO, Dominio Amigo S.A.S , commented, "Domainmonster was ... both ccTLD and gTLD launches, securing the very best Internet real estate,for their ...
... LONDON , April 27, 2010 Imperial Tobacco today,announces ... with online financial broadcaster http://www.cantos.com ,Chief Executive Gareth Davis ... our business and the success of our enhanced,focus on sales". , ... Davis hands ...
Cached Biology News:Tyco International To Pursue Spin-Off of Electrical & Metal Products Business 2Tyco International To Pursue Spin-Off of Electrical & Metal Products Business 3Dominio Amigo Announce Domainmonster as .CO Technical Partner 2Dominio Amigo Announce Domainmonster as .CO Technical Partner 3Imperial Tobacco - 2010 Half Year Results Interviews 2
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... ,Product Information , ,The ... quality, general purpose shaker with economical analog control. ... in the line, the Orbit LS features a ... controls are utilized for setting speed and time. ...
... CromoCenSC is a chromogenic medium for ... of Salmonella (except S. thyphi) and ... ,The detection takes a maximum of ... tests, no sterilization during preparation and ...
... provider of X-ray crystallography services for ... services to its pharmaceutical and biotechnology ... of drug-like fragments to the active ... allowing scientists to develop novel, high-affinity ...
Biology Products: